Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,331 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Emergency double unrelated umbilical cord blood transplant for acute lymphoblastic leukemia after very late deferral of bone marrow donor.
Sarkodee-Adoo C, Alvarnas J, Briggs A, Schriber J, Karanes C, Nademanee A, Chiffelle R, Gach R, Sulski G, Rakkar A, Forman S. Sarkodee-Adoo C, et al. Among authors: forman s. Bone Marrow Transplant. 2008 Apr;41(7):675-6. doi: 10.1038/sj.bmt.1705949. Epub 2007 Dec 17. Bone Marrow Transplant. 2008. PMID: 18084336 No abstract available.
Phase-2 trial of an intensified conditioning regimen for allogeneic hematopoietic cell transplant for poor-risk leukemia.
Stein AS, O'Donnell MR, Synold TW, Dagis AC, Tsirunyan A, Nademanee AP, Parker PM, Pullarkat VA, Snyder DS, Spielberger RT, Wong JY, Alvarnas JC, Thomas SH, Forman SJ. Stein AS, et al. Among authors: forman sj. Bone Marrow Transplant. 2011 Sep;46(9):1256-62. doi: 10.1038/bmt.2010.295. Epub 2010 Dec 13. Bone Marrow Transplant. 2011. PMID: 21151180 Free PMC article. Clinical Trial.
Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies.
Rodriguez R, Parker P, Nademanee A, Smith D, O'Donnell MR, Stein A, Snyder DS, Fung HC, Krishnan AY, Popplewell L, Cohen S, Somlo G, Angelopoulou M, Al-Kadhimi Z, Falk PM, Spielberger R, Kogut N, Sahebi F, Senitzer D, Slovak M, Schriber J, Forman SJ. Rodriguez R, et al. Among authors: forman sj. Bone Marrow Transplant. 2004 Jun;33(11):1123-9. doi: 10.1038/sj.bmt.1704493. Bone Marrow Transplant. 2004. PMID: 15064696 Clinical Trial.
A phase II study of sirolimus, tacrolimus and rabbit anti-thymocyte globulin as GVHD prophylaxis after unrelated-donor PBSC transplant.
Khaled SK, Palmer J, Stiller T, Senitzer D, Maegawa R, Rodriguez R, Parker PM, Nademanee A, Cai JL, Snyder DS, Karanes C, Osorio E, Thomas SH, Forman SJ, Nakamura R. Khaled SK, et al. Among authors: forman sj. Bone Marrow Transplant. 2013 Feb;48(2):278-83. doi: 10.1038/bmt.2012.175. Epub 2012 Sep 24. Bone Marrow Transplant. 2013. PMID: 23000644 Free PMC article. Clinical Trial.
Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer.
Morgan RJ, Doroshow JH, Leong L, Schriber J, Shibata S, Forman S, Hamasaki V, Margolin K, Somlo G, Alvarnas J, McNamara M, Longmate J, Raschko J, Chow W, Vasilev S, McGonigle K, Yen Y. Morgan RJ, et al. Among authors: forman s. Bone Marrow Transplant. 2001 Nov;28(9):859-63. doi: 10.1038/sj.bmt.1703243. Bone Marrow Transplant. 2001. PMID: 11781646 Clinical Trial.
Maintenance thalidomide following single cycle autologous peripheral blood stem cell transplant in patients with multiple myeloma.
Sahebi F, Spielberger R, Kogut NM, Fung H, Falk PM, Parker P, Krishnan A, Rodriguez R, Nakamura R, Nademanee A, Popplewell L, Frankel P, Ruel C, Tin R, Ilieva P, Forman SJ, Somlo G. Sahebi F, et al. Among authors: forman sj. Bone Marrow Transplant. 2006 May;37(9):825-9. doi: 10.1038/sj.bmt.1705339. Bone Marrow Transplant. 2006. PMID: 16565743 Clinical Trial.
Thymoglobulin, CYA and mycophenolate mofetil as GVHD prophylaxis for reduced-intensity unrelated donor hematopoietic cell transplantation: beneficial effect seen on chronic GVHD.
Rodriguez R, Nademanee A, Palmer JM, Parker P, Nakamura R, Snyder D, Pullarkat V, Zain J, Smith E, Sahebi F, Patane K, Senitzer D, Chang K, Forman SJ. Rodriguez R, et al. Among authors: forman sj. Bone Marrow Transplant. 2010 Jan;45(1):205-7. doi: 10.1038/bmt.2009.112. Epub 2009 Jun 8. Bone Marrow Transplant. 2010. PMID: 19503110 Clinical Trial. No abstract available.
Interleukin-2-activated autologous bone marrow and peripheral blood stem cells in the treatment of acute leukemia and lymphoma.
Margolin KA, Van Besien K, Wright C, Niland J, Champlin R, Fung HC, Kashyap A, Molina A, Nademanee AP, O'Donnell MR, Parker P, Smith E, Spielberger R, Somlo G, Snyder D, Stein A, Woo D, Thomas M, Sniecinski I, Forman SJ. Margolin KA, et al. Among authors: forman sj. Biol Blood Marrow Transplant. 1999;5(1):36-45. doi: 10.1053/bbmt.1999.v5.pm10232739. Biol Blood Marrow Transplant. 1999. PMID: 10232739 Free article. Clinical Trial.
1,331 results